Key result
Top quartile hs-cTnT predicts ~44% greater 30-day mortality in non-cardiac ICU patients.
Why the study?
Both hs-cTnT and NT-proBNP are frequently elevated in critically ill patients without acute cardiac disease, complicating interpretation and leaving their relative prognostic importance uncertain.
Does measurement of hs-cTnT and NT-proBNP at ICU admission predict 30-day mortality in non-cardiac critically ill patients?
Cohort (n=827)
No
Does measurement of hs-cTnT and NT-proBNP at ICU admission predict 30-day mortality in non-cardiac critically ill patients?
Effect estimate: HR 1.44 (95% CI 1.05-1.96)
p-value: p=0.022
In non-cardiac critically ill patients, hs-cTnT measured at ICU admission is an independent predictor of 30-day mortality, whereas NT-proBNP is not.
May refine mortality risk stratification in non-cardiac ICU patients; hypothesis-generating and should not yet change practice.
High-sensitivity cardiac troponin T (hs-cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are organ-specific biomarkers reflecting myocardial injury and cardiac biomechanical stress, respectively. Yet, neither is disease-specific, and both are frequently elevated in critically ill patients even in the absence of acute cardiac disease. This lack of specificity complicates their interpretation, and their relative prognostic importance remains uncertain. We retrospectively analyzed 827 adults admitted to ICU, excluding acute cardiac admissions and compared the prognostic utility of hs-cTnT and NT-proBNP measured at ICU admission for predicting 30-day mortality in non-cardiac critically ill patients. Non-survivors had higher hs-cTnT (67.2 vs. 37.7 ng/L; p < 0.001) and NT-proBNP (2340.5 vs. 1087.0 pg/mL; p < 0.001). In multivariable Cox models, only hs-cTnT remained independently predictive (highest vs. lowest hs-cTnT quartile: HR 1.44, 95% CI 1.05-1.96, p = 0.022). Adding hs-cTnT significantly improved the clinical base model (ΔLR χ²=14.6, p = 0.002; ΔAIC=-8.6), while NT-proBNP did not (ΔLRχ²=4.2, p = 0.240; ΔAIC = + 1.8). Including both biomarkers did not improve prediction beyond the model with hs-cTnT alone. In non-cardiac critically ill patients, hs-cTnT demonstrated independent and more consistent association with 30-day mortality than NT-proBNP. Myocardial injury, rather than cardiac biomechanical stress, may represent the more clinically relevant cardiac biomarker signal in this population.
No takes yet. Share an insight, caveat, or question.
Świstek et al. (2026) conducted a cohort in Non-cardiac critical illness (n=827). High-sensitivity cardiac troponin T (hs-cTnT) vs. Lowest quartile of hs-cTnT was evaluated on 30-day all-cause mortality (HR 1.44, 95% CI 1.05-1.96, p=0.022). High-sensitivity cardiac troponin T independently predicted 30-day mortality in non-cardiac critically ill patients, with the highest quartile increasing mortality risk by 44% (HR 1.44).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: